CNS Pharmaceuticals, Inc (CNSP) insider trading
Every open-market stock purchase and sale by CNS Pharmaceuticals, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: Faith L. Charles (Director), $34K, 5 months ago.
Last 12 months: insiders bought $34K (1 buy) and sold $0 (0 sales).
Recent CNSP insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| May 18, 2026 | Faith L. Charles (Director) | Bought | $34K |
| Mar 2, 2026 | Steve O'Loughlin (CFO) | Bought (not open market) | — |
| Mar 2, 2026 | Eric Faulkner (CTO) | Bought (not open market) | — |
| Jan 1, 2026 | Rami Levin (CEO) | Bought (not open market) | — |
| Nov 17, 2025 | Bettina M. Cockroft (Director) | Bought (not open market) | — |
| Nov 17, 2025 | Faith L. Charles (Director) | Bought (not open market) | — |
| Nov 17, 2025 | Amy Mahery (Director) | Bought (not open market) | — |
| Nov 17, 2025 | Christopher Downs (CFO) | Bought (not open market) | — |
| Nov 17, 2025 | Jeffry R. Keyes (Director) | Bought (not open market) | — |
| Nov 17, 2025 | John M Climaco (CEO) | Bought (not open market) | — |
| Nov 17, 2025 | Jerzy Gumulka (Director) | Bought (not open market) | — |
Who's trading CNSP
- Faith L. Charles, Director: bought $34K (1 buy), last May 18, 2026
- Steve O'Loughlin, CFO: other filings, last Mar 2, 2026
- Eric Faulkner, CTO: other filings, last Mar 2, 2026
- Rami Levin, CEO: other filings, last Jan 1, 2026
- John M Climaco, CEO: other filings, last Nov 17, 2025
- Jerzy Gumulka, Director: other filings, last Nov 17, 2025
- Jeffry R. Keyes, Director: other filings, last Nov 17, 2025
- Bettina M. Cockroft, Director: other filings, last Nov 17, 2025
- Christopher Downs, CFO: other filings, last Nov 17, 2025
- Amy Mahery, Director: other filings, last Nov 17, 2025
Get free alerts when an insider at CNS Pharmaceuticals, Inc files a new trade →